US manufacturer cannot supply Wegovy injector pen syringes

Novo Nordisk will struggle to meet demand for its Wegovy injector pens during the first half of 2022.

Photo: Novo Nordisk / PR

Novo Nordisk will have supply problems concerning its Wegovy injector pens during the first half of 2022 on the US market, the Danish pharmaceutical company reports.

A sub-contractor which fills the syringes used in Wegovy injector pens for the US market has temporarily suspended deliveries and production after problems with "acceptable production practice."

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs